{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:20:27Z","timestamp":1787239227116,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neubiorev.2025.106493","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:07:44Z","timestamp":1764202064000},"page":"106493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effects of psychedelic microdosing on cognitive functions: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2063-3083","authenticated-orcid":false,"given":"Netta","family":"Pinhas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nofar","family":"Eidlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avigail","family":"Barnea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leehe","family":"Peled-Avron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.neubiorev.2025.106493_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv039","article-title":"Serotonergic psychedelics temporarily modify information transfer in humans","volume":"18","author":"Alonso","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106493_bib2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.tics.2016.10.002","article-title":"Cognitive control as a double-edged sword","volume":"20","author":"Amer","year":"2016","journal-title":"Trends Cogn. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12954-019-0308-4","article-title":"Psychedelic microdosing benefits and challenges: An empirical codebook","volume":"16","author":"Anderson","year":"2019","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.neubiorev.2025.106493_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116462","article-title":"Decreased directed functional connectivity in the psychedelic state","volume":"209","author":"Barnett","year":"2020","journal-title":"NeuroImage"},{"issue":"10","key":"10.1016\/j.neubiorev.2025.106493_bib5","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2019.05.019","article-title":"Acute subjective and behavioral effects of microdoses of lysergic acid diethylamide in healthy human volunteers","volume":"86","author":"Bershad","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106493_bib6","first-page":"461","article-title":"Preliminary report on the effects of a low dose of LSD on resting-state amygdala functional connectivity","volume":"5","author":"Bershad","year":"2020","journal-title":"Biol. Psychiatry Cogn. Neurosci. neuroimaging"},{"key":"10.1016\/j.neubiorev.2025.106493_bib7","series-title":"In Principles of frontal lobe function","first-page":"428","article-title":"The role of prefrontal cortex in normal and disordered cognitive control: A cognitive neuroscience perspective","author":"Braver","year":"2002"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0896-6273(01)00583-9","article-title":"Immature frontal lobe contributions to cognitive control in children: evidence from fMRI","volume":"33","author":"Bunge","year":"2002","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106493_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neubiorev.2025.106493_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: Six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41398-022-02039-0","article-title":"Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study","volume":"12","author":"Cavanna","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106493_bib13","series-title":"The Handbook of Research Synthesis and Meta-Analysis","author":"Cooper","year":"2019"},{"key":"10.1016\/j.neubiorev.2025.106493_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.15406\/jpcpy.2023.14.00738","article-title":"Microdosing psychedelics has no impact on cognitive function in naturalistic settings","volume":"14","author":"Dinkelacker","year":"2023","journal-title":"J. Psychol. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/brain\/awab406","article-title":"Models of psychedelic drug action: modulation of cortical-subcortical circuits","volume":"145","author":"Doss","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40614-021-00303-0","article-title":"Meta-analytic methods to detect publication bias in behavior science research","volume":"45","author":"Dowdy","year":"2022","journal-title":"Perspect. Behav. Sci."},{"issue":"1915","key":"10.1016\/j.neubiorev.2025.106493_bib18","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2023.0095","article-title":"Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study","volume":"379","author":"Enriquez-Geppert","year":"2024","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"10.1016\/j.neubiorev.2025.106493_bib19","series-title":"The Psychedelic Explorer\u2019s Guide: Safe, Therapeutic, and Sacred Journeys","author":"Fadiman","year":"2011"},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106493_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106493_bib21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3389\/fnhum.2014.00680","article-title":"An information theory account of cognitive control","volume":"8","author":"Fan","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neubiorev.2025.106493_bib22","first-page":"571","article-title":"Chapter 33\u2014The role of serotonin in performance monitoring and cognitive control","volume":"31","author":"Fischer","year":"2020"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41386-022-01479-y","article-title":"Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity","volume":"48","author":"Glazer","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.neubiorev.2025.106493_bib24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2025.106493_bib25","article-title":"Honors Undergraduate Theses","author":"Harris","year":"2021","journal-title":"Eff. Micro Class. Psychedelics Cogn. Perform."},{"issue":"3","key":"10.1016\/j.neubiorev.2025.106493_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2025.106493_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.euroneuro.2020.10.002","article-title":"Mood and cognition after administration of low LSD doses in healthy volunteers: a placebo controlled dose-effect finding study","volume":"41","author":"Hutten","year":"2020","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106493_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2025.106493_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuroimage.2019.03.075","article-title":"Resting state functional connectivity and cognitive task-related activation of the human claustrum","volume":"196","author":"Krimmel","year":"2019","journal-title":"NeuroImage"},{"key":"10.1016\/j.neubiorev.2025.106493_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.11.008","article-title":"Microdosing psychedelics: motivations, subjective effects and harm reduction","volume":"75","author":"Lea","year":"2020","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/nc\/nix016","article-title":"Self unbound: Ego dissolution in psychedelic experience","volume":"2017","author":"Letheby","year":"2017","journal-title":"Neurosci. Conscious."},{"key":"10.1016\/j.neubiorev.2025.106493_bib32","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41386-023-01607-2","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","volume":"48","author":"Ley","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106493_bib33","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41386-019-0360-5","article-title":"Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/02698811211050556","article-title":"Psilocybin microdosing does not affect emotion-related symptoms and processing: a preregistered field and lab-based study","volume":"36","author":"Marschall","year":"2022","journal-title":"J. Psychopharmacol. (Oxf. Engl. )"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41398-021-01335-5","article-title":"Spontaneous and deliberate creative cognition during and after psilocybin exposure","volume":"11","author":"Mason","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2025.106493_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2014.00048","article-title":"The claustrum in review","volume":"8","author":"Mathur","year":"2014","journal-title":"Front. Syst. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106493_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.biopsych.2023.03.013","article-title":"Acute mood-elevating properties of microdosed lysergic acid diethylamide in healthy volunteers: a home-administered randomized controlled trial","volume":"94","author":"Murphy","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00213-024-06680-z","article-title":"Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide","volume":"242","author":"Murphy","year":"2024","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.neubiorev.2025.106493_bib40","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00213-021-05991-9","article-title":"Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults","volume":"239","author":"Murray","year":"2022","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2025.106493_bib41","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41386-024-01809-2","article-title":"Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine","volume":"49","author":"Murray","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3758\/s13415-011-0083-5","article-title":"Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions","volume":"12","author":"Niendam","year":"2012","journal-title":"Cogn. Affect. Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106493_bib44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0269881120981384","article-title":"Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings","volume":"35","author":"Pallavicini","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106493_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104706","article-title":"The emerging science of microdosing: a systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field","volume":"139","author":"Polito","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211023","article-title":"A systematic study of microdosing psychedelics","volume":"14","author":"Polito","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.neubiorev.2025.106493_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/7854_2016_459","article-title":"Phenomenology, structure, and dynamic of psychedelic states","volume":"36","author":"Preller","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"12","key":"10.1016\/j.neubiorev.2025.106493_bib48","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","article-title":"Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting","volume":"235","author":"Prochazkova","year":"2018","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.neubiorev.2025.106493_bib49","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2025.106493_bib50","article-title":"Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls","volume":"12","author":"Rootman","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neubiorev.2025.106493_bib51","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.neuron.2022.12.031","article-title":"The costs and benefits of psychedelics on cognition and mood","volume":"111","author":"Sayali","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2025.106493_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/srep46421","article-title":"Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin","volume":"7","author":"Schartner","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/02791072.2005.10399798","article-title":"EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences","volume":"37","author":"Stuckey","year":"2005","journal-title":"J. Psychoact. Drugs"},{"issue":"11","key":"10.1016\/j.neubiorev.2025.106493_bib54","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","volume":"25","author":"Studerus","year":"2011","journal-title":"J. Psychopharmacol. (Oxf. Engl. )"},{"key":"10.1016\/j.neubiorev.2025.106493_bib55","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62878","article-title":"Self-blinding citizen science to explore psychedelic microdosing","volume":"10","author":"Szigeti","year":"2021","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.neubiorev.2025.106493_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51974-4","article-title":"Neural correlates of the DMT experience assessed with multivariate EEG","volume":"9","author":"Timmermann","year":"2019","journal-title":"Sci. Rep."},{"issue":"6633","key":"10.1016\/j.neubiorev.2025.106493_bib57","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science (New York N. Y. )"},{"key":"10.1016\/j.neubiorev.2025.106493_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"issue":"17","key":"10.1016\/j.neubiorev.2025.106493_bib59","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.neubiorev.2025.106493_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13143","article-title":"Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study","volume":"27","author":"de Wit","year":"2022","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neubiorev.2025.106493_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117703","article-title":"Activation of the cognitive control network associated with information uncertainty","volume":"230","author":"Wu","year":"2021","journal-title":"NeuroImage"},{"issue":"4","key":"10.1016\/j.neubiorev.2025.106493_bib62","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00213-018-5119-x","article-title":"The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial","volume":"236","author":"Yanakieva","year":"2019","journal-title":"Psychopharmacology"}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425004944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763425004944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T08:48:59Z","timestamp":1781167739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763425004944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["S0149763425004944"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106493","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of psychedelic microdosing on cognitive functions: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106493"}}